Senior Medical Science Liaison (MSL) – Hematology/Oncology
Location: Europe
Department: Clinical Development
Reports to: SVP, Medical Affairs
Company Overview
Terns Pharmaceuticals is a global biopharmaceutical company committed to developing transformative therapies for patients with serious diseases. With a pipeline of innovative oncology programs, including TERN-701, a next-generation allosteric BCR-ABL inhibitor now advancing into pivotal clinical trials for chronic myeloid leukemia (CML), we are dedicated to building a future where precision medicines improve patient lives and outcomes.
Position Summary
The Senior Medical Science Liaison (MSL) will serve as a trusted scientific partner to healthcare providers, researchers, and key stakeholders in the hematology/oncology community. This field-based role will focus on delivering scientific exchange, supporting clinical development programs, and generating insights to inform Terns’ strategy as TERN-701 progresses through pivotal trials. The Sr. MSL will be a critical interface between the company and external experts, ensuring alignment of scientific messaging and supporting successful trial execution and future product launch readiness.
Key Responsibilities
- Scientific Exchange & Education
- Develop and foster effective and trusting peer-level relationships with Thought Leaders (TLs), investigators, and healthcare decision-makers in hematology/oncology.
- Maintain clinical, scientific and technical expertise in CML.
- Communicate accurate, balanced, and timely scientific and clinical information about TERN-701 and other pipeline assets.
- Collaborate to advance Medical Affairs initiatives by providing scientific expertise and support to scientific communication plan, medical education initiatives, advisory boards, and medical congress activities.
- Facilitate research collaborations such as investigator-initiated trials. Provide medical interpretation of data from clinical trials, registries, and published literature in CML
- Perform medical/scientific training for internal stakeholders (as applicable).
- Clinical Development Support
- Identify and engage potential clinical trial investigators and research sites for pivotal studies.
- Provide scientific support for ongoing trials, including discussion of study rationale, protocol design, enrollment strategies, and providing end of study data reviews with investigators (as needed).
- Collect and communicate clinical insights from investigators and study staff to inform development decisions.
- Medical Affairs Insights
- Gather, analyze, and share scientific intelligence on therapeutic landscape, competitor activity, and unmet medical needs to support the development of therapeutic strategy
- Independently incorporates the medical plan into interactions and territory planning (i.e. listening priorities) and captures valuable feedback to inform internal stakeholders and assist in shaping the medical strategy. Partner cross-functionally with Clinical Development, Regulatory, and Commercial teams to inform strategic planning. Contribute to publication planning, medical education, and pre-launch activities for TERN-701.
Qualifications
- Advanced scientific/clinical degree required (PhD, PharmD, MD, or equivalent).
- 5–7+ years’ experience in Medical Affairs, preferably with 3+ years as an MSL in hematology/oncology.
- Strong knowledge of CML, targeted therapies, and oncology clinical trial design.
- Proven ability to build relationships with TLs and investigators at academic centers and community practices.
- Exemplifies a strong patient-centric approach, grounded in the highest standards of medical professionalism
- Excellent communication, presentation, and scientific acumen skills.
- Agile, adaptable, results orientated
- Team player with the ability to collaborate in a cross-functional environment. Ability to travel frequently (60–70% depending on territory needs).
Competencies:
- Strategic Thinking: Ability to develop long-term strategies for the field medical function.
